Recon: Lilly's obesity pill reduced weight, blood sugar in late-stage trial; EU approves Gilead’s HIV PREP injection

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States